Embryonic stem (ES) cells which constitutively express the Pdx-1, Ngn-3, NeuroD1, Nkx2.2, and Nkx6.1 transcription factors were engineered by means of lentiviral vectors, following a multi-step infection procedure to successively generate ES cell lines expressing one, two, and three factors, respectively. Each ES cell line was allowed to differentiate into nestin + /Isl-1 + endocrine precursors, then into more mature pancreatic cells, and subsequently analysed for expression of Glc, Ins, and Sst, markers of α α α α α, β β β β β and δ δ δ δ δ cells, respectively. Each ES cell line generated displayed a unique pattern of gene expression. The ES cell line expressing NeuroD1 displayed vastly elevated levels of Glc, Ins-1, Ins-2 and Sst, and showed an increase in Pdx-1, Pax-4, Nkx6.1,  Isl-1, Glut-2 and GK transcript levels. Furthermore, immunofluorescence analysis revealed that differentiation of NeuroD1-expressing ES cells in nestin + /Isl-1 + multilineage progenitors, followed by the formation of C-peptide + /insulin + clusters, was accelerated. Together, these results indicate that stable expression of NeuroD1 in ES cells facilitates differentiation into endocrine and insulinproducing cells.
Introduction
Embryonic stem (ES) cells are derived from the pluripotent cells of the blastocyst stage embryo. They are able to self-renew indefinitely in vitro while retaining pluripotency and to differentiate into diverse cell types of ectodermal, mesodermal and endodermal lineages (Smith, 2001; Wobus and Boheler, 2005) . The differentiation of ES cells into insulin-producing β-like cells constitutes a field of intensive investigations as it represents a possible alternative both to the use of immortalized endocrine cell lines for drug screening and functional genomics and to the limited availability of human islets needed for transplantation in type I diabetes therapy Bonner-Weir and Weir, 2005; Nir responsible for hormone production. The endocrine α, β, δ and PP cells are secreting glucagon, insulin, somatostatin and pancreatic polypeptide, respectively. During embryonic development, the pancreas arises as dorsal and ventral buds from the definitive endoderm layer. This complex and regulated process involves the integration of signals from adjacent mesodermal tissues (reviewed in Kumar et al., 2003) . Information provided by these signals activates a cascade of transcription factor expression (reviewed in Jensen, 2004; Bonal and Herrera, 2008) leading to differentiation and proliferation of pancreatic cells within the competent endoderm. Among known transcription factors, pancreatic duodenal homeobox 1 (Pdx-1 or Ipf1), a homeodomain protein, is involved in the development of pancreatic progenitor cells (Offield et al., 1996; Gu et al., 2002) , and in insulin gene transcription and glucose response in mature β cells (Holland et al., 2002) . Gain-of-function studies indicate that neurogenin 3 (Ngn-3) and neurogenic differentiation 1 (NeuroD1), two bHLH factors, share the common ability to drive endocrine differentiation in the appropriate cell context (Apelqvist et al., 1999; Schwitzgebel et al., 2000) (Heremans et al., 2002) (Gasa et al., 2004) . However, loss-of-function studies in mice revealed important differences in the roles of these two factors during endocrine differentiation. While Ngn-3 null animals lack all pancreatic endocrine cells (Gradwohl et al., 2000) , NeuroD1 null mice die postnatally from severe diabetes due to a dramatic loss of insulin-producing β cells, whereas the numbers of glucagon-producing α cells and somatostatin-producing δ cells are only modestly reduced (Naya et al., 1997) . Lineage tracing experiments indicate that Ngn-3 is a cell-autonomous determinant and a true marker of endocrine progenitor cells (Gu et al., 2002) . Taken together, these data suggest that the transient expression of Ngn-3 in the developing pancreas epithelium specifies which cells among the Pdx-1 + pancreatic progenitor pool will follow an endocrine fate, while its downstream target NeuroD1 carries on the endocrine differentiation program initiated by Ngn-3 and participates in the maintenance of the differentiated phenotype of the mature islet cells. The differentiation of Ngn3 + endocrine progenitor cells through the β cell pathway also requires the expression of other factors, such as Nkx2.2 (Sussel et al., 1998 ), Pax-4 (Sosa-Pineda et al., 1997 and Nkx6.1 (Sander et al., 2000) . NeuroD1 and Nkx2.2 are also involved in the regulation of insulin gene transcription in mature β cells (Naya et al., 1995) (Cissell et al., 2003) .
Over the past few years, insulin-producing cells were derived from both mouse and human ES cells. Insulin-producing cells were obtained from ES cells by spontaneous differentiation (Assady et al., 2001; Kahan et al., 2003) , lineage selection using pancreasspecific promoters (Soria et al., 2000; Leon-Quinto et al., 2004) , directed differentiation using growth factor-based stepwise protocols (reviewed in Blyszczuk et al., 2004) or co-culture with embryonic pancreatic buds (Vaca et al., 2006) (Brolen et al., 2005) . More recently, pancreatic-hormone-expressing endocrine cells (D'Amour et al., 2006; Kroon et al., 2008) and insulin-producing islet-like clusters (Jiang et al., 2007) were generated by using growth factors and signalling molecules stimulating the in vitro formation of definitive endoderm and the in vivo development of functional β-like cells from human ES cells. The overexpression of transcription factors, such as Pdx-1 (Lavon et al., 2006) , Ngn-3 (Treff et al., 2006) , Nkx2.2 (Shiroi et al., 2005) or Pax-4 , in ES cells has been shown to facilitate their differentiation into insulin-producing cells.
In the present work, we report the generation of mouse ES cell lines stably expressing Pdx-1, Ngn-3, NeuroD1, Nkx2.2 and Nkx6.1. We studied the capacity of these ES cell lines to differentiate into endocrine cells by using the threestep protocol via multilineage progenitors established by Blyszczuk et al. (2004) , shown to result in the formation of functional glucoseresponsive insulin-producing cells (Boyd et al., 2008) . The data presented show that NeuroD1 over-expression increases the expression of endocrine markers and facilitates differentiation of pancreatic precursors into insulin-producing cells.
Results

Generation of genetically modified ES cell lines stably expressing Pdx1, Ngn-3, NeuroD1, Nkx2.2, and Nkx6.1 transcription factors
ES cell lines that constitutively express the Pdx-1, Ngn-3, NeuroD1, Nkx2.2 and Nkx6.1 genes were engineered from CGR8 cells (here-
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Pdx-1-ESCs analysed by immunofluorescence in undifferentiated ES cells using specific antibodies ( Fig. 2 ). Immunostaining was specific and localized in the nucleus in all clones analysed. To determine if transgene expression compromised self-renewal, all clones were analysed for expression of the pluripotency markers Oct-4 and Nanog by flow cytometry. This analysis revealed differences in the percentage of cells expressing Oct-4 and Nanog, ranging from 40% to 96% in transgenic ES cell lines, compared to 80% in control ES cells ( Fig. 3 and Supplementary Fig. 1 ). Therefore, constitutive expression of most transgenes obviously affects expression levels of the pluripotency-associated genes Oct4 and Nanog, which may lead to an increased rate of spontaneous differentiation. However, all transgenic ES cell lines could be propagated for several months in culture and formed embryoid bodies (EBs) upon growth in suspension (see next sections), indicating that they retained strong self-renewal capabilities.
NeuroD1-ES cells exhibit strongly increased expression of endocrine markers after differentiation
ES cell lines were induced to differentiate via EBs, as described previously Schroeder et al., 2006; Boyd et al., 2008) . Expression of the endocrine markers insulin-1 (ins-1), insulin-2 (ins-2), glucagon (Glc) and somatostin (Sst) was analysed at differentiation stage 5+28d. During mouse embryonic development, Ins-1 is only expressed in β-cells, while ins-2 is expressed both in β-cells and in the developing brain (Deltour et al., 1993) . Glc and Sst expression characterizes α and δ cells of the Langerhans islets, respectively. Nkx2.2-ESC, Pdx-1/Nkx6.1-ESC, Pdx-1/Nkx2.2/Nkx6.1/NeuroD1-ESC showed a strong increase in Glc expression after differentiation, when compared to after called WT-ESC). This was achieved by means of lentiviral vector infection and sub-cloning following a multi-step infection procedure to successively generate ES cell lines expressing one, two, and three transcription factors (Fig. 1A ). An ES cell line expressing the Green Fluorescent Protein (GFP) was used as control (hereafter called GFP-ESC). In a first step, ES cell lines expressing one single transcription factor (Pdx-1, Ngn-3, NeuroD1, Nkx6.1, and Nkx2.2) were generated. For differentiation studies, clones expressing transduced genes at the highest level were selected for subsequent infection steps: clone #1 expressing Pdx-1 (hereafter called Pdx1-ESC), clone #1 expressing Ngn-3 (hereafter called Ngn3-ESC), clone #10 expressing NeuroD1 (hereafter called NeuroD1-ESC), clone #7 expressing Nkx6.1 (hereafter called Nkx6.1-ESC), clone #13 expressing Nkx2.2 (hereafter called Nkx2.2-ESC) ( Fig. 1B) . In a second step, Pdx1-ESC was re-infected with the lentiviral vectors expressing Ngn-3, NeuroD1, and Nkx6.1, respectively. Clones (hereafter called Pdx1/Ngn3-ESC, Pdx1/ NeuroD1-ESC and Pdx1/Nkx6.1-ESC) were selected for differentiation analysis. Similarly, Nkx2.2-ESC was re-infected with the lentiviral vector expressing Nkx6.1 to generate Nkx2.2/Nkx6.1-ESC, and with the lentiviral vector expressing Pdx-1 to generate Nkx2.2/Pdx1-ESC lines. The Nkx2.2/Nkx6.1-ESC line was subsequently re-infected with the lentiviral vector expressing Pdx-1 to generate Nkx2.2/Nkx6.1/Pdx-1-ESC.
Transgene expression was the GFP control line, whereas expression of the other endocrine markers analysed were not different to the control (Fig.  4A ). Pdx-1/Nkx2.2-ESC showed a strong increase in ins-2 expression at 5+28d of differentiation. Pdx-1/Ngn-3-ESC showed an increase in both ins-1 and ins-2 expression, but Glc expression remained below detection level. In contrast, Ngn3-ESC and NeuroD1-ESC showed a strong increase in the expression of all four endocrine markers. NeuroD1-ESC showed the highest increase in Glc level. Strong induction of Glc, Sst, Ins-1 and Ins-2 expression at differentiation stage 5+28d in NeuroD1-ESC was confirmed in an independent experiment ( Fig. 4B ). When compared to WT-ESC, NeuroD1-ESC showed a significant increase in Glc expression (24 +/-2.4 fold, p < 0.01, n = 3), in ins-1 expression (13 +/-2.7 fold, p < 0.05, n = 3), and in Sst expression (10 +/-0.2 fold, p < 0.001, n = 3). Ins-2 expression was moderately increased (6 +/-1.2 fold, p < 0.2, n= 3).
NeuroD1-ESC also showed a strong increase in the expression of the endocrine transcription factors Pdx-1, Nkx6.1, Pax-6 and Isl-1 ( Fig. 4C ). Nkx2.2 is the only factor analysed which did not show elevated expression. Expression of the β-cellspecific glucose transporter-2 (Glut-2) and glucokinase (GK) genes was also strongly up-regulated in NeuroD1-ESC compared to WT-ESC. Of note, only low transcript levels of the neuronal genes Nfm (neurofilament heavy chain) and Syn (synaptophysin) were seen in NeuroD1-ESC. Nfm and Syp expression disappeared after differentiation under reduced glucose conditions (data not shown).
Together, these results show that stable expression of NeuroD1 in ES cells dramatically increases the expression of endocrine and β-cell markers upon differentiation.
NeuroD1 over-expression increases proliferation of nestin + precursors and accelerates formation of pancreatic-committed progenitors
NeuroD1-ESC showed increased cell proliferation during in vitro differentiation relative to control, evidenced by a rapid exhaustion of medium and a dramatic overgrowth at stage 5+28d. We asked if the population of precursor cells exhibited an increased proliferation rate. To this aim, a proliferation assay based on BrdU incorporation was performed during WT-ESC and NeuroD1-ESC differentiation. Nestin + progenitors in the S-phase of the cell cycle (BrdU + ) were detected by doubleimmunofluorescence ( Fig. 5A) . No difference in the frequency of nestin + /BrdU + cells was observed between WT-ESC and NeuroD1-ESC until differentiation stage 5+7d. By contrast, from differentiation stage 5+9d onwards, when multilineage progenitors (5+9d) and committed precursors (5+12, 5+16d) form (see Blyszczuk et al., 2004) , a larger fraction of nestin + precursors derived from NeuroD1-ESC were BrdU + (5+9d: 1.6 +/-0.2 fold, p < 0.05, n = 4; 5+12d: 1.5 +/-0.3 fold, p < 0.05, n = 4; 5+16d:1.5 +/-0.2 fold, p <0.05, n = 4). These results indicate that NeuroD1-ESC-derived nestin + progenitors exhibit a higher proliferation rate.
At early stage 5+9d, pancreatic progenitors can be distinguished by the co-expression of neurofilament nestin and cytokeratin 19 (CK19). By contrast, at stage 5+16d, nestin is coexpressed with Isl-1, a LIM homeodomain protein that controls cell-fate decision required for the differentiation of islet cells (Ahlgren et al., 1997) . Double labelling of nestin and Isl-1 has been used to characterize endocrine-committed pancreatic progenitors from stage 5+16d onwards . Immunostaining of nestin + /Isl-1 + cells was performed during differentiation of WT-ESC and NeuroD1-ESC to identify endocrine-committed progenitors. In WT-ESC, nestin + /Isl-1 + clusters were first detected at stage 5+16d as previously described (data not shown, see ). Some occasional nestin + /Isl-1 + cells were detectable as early as stage 5+9d, but they were dispersed and did not form clusters (Fig.  5B ). This contrasted with NeuroD1-ESC that showed numerous nestin + /Isl-1 + positive cells organized in clusters as early as stage 5+9d. These results suggest that in NeuroD1-ESC the formation of nestin + /Isl-1 + endocrine-committed progenitors is accelerated.
NeuroD1 overexpression accelerates the formation of insulin-producing clusters
NeuroD1-ESC showed an elevated expression of β-cell markers in differentiated cells at 5+28d (Fig. 4) . We then asked if the yield of C-peptide + /insulin + cells was increased. Double immunostaining for insulin and C-peptide was performed at the differentiation stage of 5+16d ( Fig. 5 ). NeuroD1-ESC formed 3.4-fold more C-peptide + /insulin + clusters than control WT-ESC (Fig. 6A) . Moreover, NeuroD1-ESC-derived clusters contained a high number of insulin-positive cells (Fig. 6B ). In contrast, WT-ESC-derived clusters displayed occasional insulin + cells, which seldom formed typical clusters at stage 5+16d. With WT-ESC, the typical clusters were only observed at the terminal stage of 5+28d (see Blyszczuk et al., 2004; Schroeder et al., 2006) . Together, these observations indicate that in NeuroD1-ESC the formation of C-peptide + /ins + clusters is accelerated. NeuroD1 promotes endocrine differentiation of ES cells 573
Discussion
The aim of this study was to examine the ability of engineered mouse ES cells to differentiate into pancreatic endocrine cells following a differentiation protocol previously optimized for differentiation into insulin-producing cells Schroeder et al., 2006) . This protocol was confirmed to be efficient in generating functional glucose-responsive insulinproducing cells (Boyd et al., 2008) and to induce the generation of other cell types of the islet of Langerhans, such as αand δ-cells (Schroeder et al., 2006; Boyd et al., 2008) . Following this protocol, a fraction of the cell population differentiates into pancreatic precursor-like cells, evidenced by the co-expression of the neurofilament nestin and the endocrine-specific transcription factor Isl-1. At a later stage, they further differentiate into insulinproducing cells organized in clusters. The fraction of cells adopting a β-like phenotype can be significantly increased by overexpressing the transcription factor Pax-4 Schroeder et al., 2006) , which suggests that expression of endogenous Pax-4 is rate-limiting for β-cell differentiation.
The rationale of our experimental approach relies on the assumption that the differentiation protocol does not allow effi- Jonsson et al., 1994; Gu et al., 2002) , of the endocrine lineage (Ngn-3, Gradwohl et al., 2000) , and of the β-cell lineage (NeuroD1, Nkx2. 2, Nkx6.1, Naya et al., 1997; Sussel et al., 1998; Sander et al., 2000) . Because endocrine differentiation is known to result from the coordinated action of several transcription factors (Jensen, 2004) (Murtaugh, 2007) , we sought to generate ES cell lines expressing multiple factors to further enhance the yield of endocrine differentiation. Real-time PCR analysis of the α, β and δ cell markers, Ins, Glc and Sst, respectively, revealed that each cell line showed a specific pattern of gene expression. ES cell lines over-expressing Nkx2.2 and Nkx6.1, either alone or in combination with Pdx1, showed no increase in insulin gene expression compared to control cells, despite Nkx2.2 and Nkx6.1 were previously shown to regulate β-cell differentiation (Sussel et al., 1998; Sander et al., 2000) . Similarly, over-expression of Pdx-1 had no effect on the yield of β-cell differentiation despite Pdx-1 is known both to be required in vivo for the development of all pancreatic cell types (Jonsson et al., 1994) (Gu et al., 2002) , and to be a critical regulator of ins gene expression in mature β-cells (Ahlgren et al., 1998; Holland et al., 2002) . It was previously reported that over-expression of Pdx-1 had only little effect on the yield of β-cell differentiation from mouse (Blyszczuk et al., 2003; Miyazaki et al., 2004) ( Takayama et al., 2008) and human ESCs (Lavon et al., 2006) . Together, these observations indicate that none of the three transcription factors Pdx-1, Nkx2.2, and Nkx6.1 is rate limiting during βcell differentiation induced in our protocol. By contrast, over-expression of Ngn-3 and NeuroD1 increased the expression of α, β and δ cell markers, NeuroD1 showing the strongest effect of both. This result is in agreement with gain-of-function studies which revealed that Ngn-3 and NeuroD1 induced endocrine differentiation when expressed ectopically in vitro (Heremans et al., 2002) (Gasa et al., 2004 ) (Treff et al., 2006) or in vivo (Apelqvist et al., 1999; Schwitzgebel et al., 2000; Grapin-Botton et al., 2001; Kojima et al., 2003; Kaneto et al., 2005) . Surprisingly, ES cell lines over-expressing Pdx-1 and NeuroD1 showed no increase in endocrine markers. We can speculate that forced expression of Pdx-1 prevents ectopic NeuroD1 from properly activating the transcription of endocrine genes in differentiating cells. Alternatively, it may be inferred that the Pdx-1/NeuroD1-ESC expresses NeuroD1 at a lower level than the NeuroD1-ESC that would make NeuroD1-associated transcriptional activity unable to activate an endocrine differentiation program in Pdx-1/NeuroD1-ESC.
In the second part of this work, we focused our study on NeuroD1-ESC that showed a vastly improved capacity for endocrine differentiation compared to all other engineered ES cell lines, including differentiation to the β-cell lineage. The influence of NeuroD1 on β-cell differentiation was evidenced by a strong increase in the expression of genes encoding Pdx-1, Nkx6.1, Pax-6, Isl-1, the glucose receptor Glut-2 and GK. These observations are in line with -and extend -the previous observations of Saitoh et al. who showed that forced expression of NeuroD1 via adenoviral vector infection restores the expression of insulin lost upon passaging of Pdx-1-expressing ES cells (Saitoh et al., 2007) . Together, these observations indicate that NeuroD1 is a ratelimiting factor during in vitro differentiation of ES cells into β-like cells.
How enforced NeuroD1 expression stimulates endocrine and β-cell differentiation is not yet clear. First, we showed that NeuroD1-ESC generates more nestin + /Isl-1 + precursors than WT-ESC at the early differentiation stage 5+9d. This suggests that, at this multilineage progenitor stage, more cells representing progenitors of all three primary germ layers, including multilineage pancreatic progenitors, are formed. This might result from an increased proliferation rate, as it was observed in the whole nestin + cell population. However, whether the proliferation of the definitive endocrine progenitor population is accelerated remains to be determined. Second, NeuroD1-ESC was found to produce insulin + /C-peptide + clusters as early as stage 5+16d, therefore approximately 12 days earlier than WT-ESC. Premature differentiation into insulin + /C-peptide + cells might result from the premature differentiation of nestin + /Isl-1 + multilineage precursors at stage 5+9d. Alternatively, it can be speculated that over-expression of NeuroD1 increases the proliferation rate of differentiating β-like cells. This hypothesis is supported by the observation that homozygous NeuroD1 null mice have a strong reduction in the number of insulin-producing β-cells. Islet morphogenesis appeared to be arrested between E14.5 and E17.5, a period char- acterized by major expansion of the β-cell population (Naya et al., 1997) . Mentionable is the dramatic growth rate that characterizes NeuroD1-ESC cultures at final stages of differentiation (beyond stage 5+16d). It results in massive cell overgrowth paralleled by high metabolic activity and subsequent failure to analyse insulin + /C-peptide + clusters at stage 5+28d. However, the elevation of β-cell marker expression (Glut-2, GK, ins-1 and ins-2) at 5+28d indicates that NeuroD1 over-expression increased the yield of β-like cell differentiation at late stages. This could result either from an increase in the fraction of cells adopting a βlike phenotype, and acceleration of the differentiation process into glucose-producing cells. Further modification of the differentiation protocol is needed to study the maturation of insulin + /C-peptide + clusters at terminal stages in vivo (Kroon et al., 2008) , in particular measure insulin release upon glucose stimulation.
Materials & Methods
Plasmid construction and lentiviral vector production pEFs-eGFP harbors the sequence encoding the enhanced green fluorescent protein driven off the minimal version of the human EF1α promoter (EFs) (Fluckiger et al. 2006) . pEFs-Pdx-1, pEFs-Ngn-3, pEFs-NeuroD1, pEFs-Nkx2.2 and pEFs-Nkx6.1 lentiviral vectors were generated from pEFs-eGFP by replacing the fragment containing the eGFP sequence by the full-length cDNAs encoding mouse Pdx-1 (5'-SalI(blunt)/ BglII-3' fragment from pZL1-Pdx1), HA-tagged mouse Ngn-3 (5'-HindIII(blunt)/EcoRV-3' fragment from pcDNAI/Amp/HA-Ngn-3), Myctagged mouse NeuroD1 (5'-BamHI/XhoI-3' fragment from pCS2 + MT-NeuroD1), hamster Nkx2.2 (5'-AvrII(blunt)/XhoI-3' fragment from pBAT12-shNkx2.2), and hamster Nkx6.1 (5'-XhoI(blunt)/XbaI(blunt)-3' fragment from pBAT12-Nkx6.1 (Rudnick et al., 1994) ). The method for producing SIV-based vectors in 293T cells is fully described elsewhere . Briefly, 293T cells were transfected with a mixture of DNAs containing 10 µg of the pGRev plasmid encoding the vesicular stomatitis virus glycoprotein (VSV-G) envelope, 10 µg of the pSIV3 + plasmid encoding the gag, pol, tat and rev proteins, and 13 µg of the pEFs plasmid encoding the cDNA of interest, using the calcium phosphate precipitation technique. The following day, cells were refed with 7 ml of DMEM and further cultured for 24 hours. The supernatant was then collected, cleared by centrifugation (3000 RPM, 15 minutes) and passed through a 0.8 µm filter. 
ES cell culture and gene transduction
Undifferentiated murine ES cells from the feeder-independent CGR8 cell line were routinely cultured in Glasgow's modified Eagle's medium (GMEM; Invitrogen, Carlsbad, CA, http:/ /www.invitrogen.com) supplemented with 10% foetal calf serum (FCS; Biowest, Nuaillé, France, www.biowest.net), 2 mM L-glutamine (Invitrogen), 100 µM non-essential amino acids (Invitrogen), 1mM sodium pyruvate (Invitrogen), 100 U/ ml penicillin-100 µg/ml streptomycin (Invitrogen), 100 µM β-mercaptoethanol (Sigma, St. Louis, http://www/sigmaaldrich.com) and 1000 U/ml of Leukemia Inhibitory Factor (LIF) as previously described (Savatier et al., 1996) . 10 5 CGR8 ES cells were infected for 5 hours with 1 ml of lentiviral supernatant supplemented with LIF, and further cultured for 48 hours. The infected cells were sub-cloned in 96 well plates. Individual colonies were amplified and transgene expression analysed by immunoblotting.
In vitro differentiation of ES cells
The protocol used for in vitro differentiation of ES cell lines was previously described Schroeder et al., 2006) . Differentiation of ES cell lines was induced by the formation of embryoid bodies (EB) using the "hanging drop" method (600 ESCs/EB) in ES cell medium without LIF. After 2 days, EBs were collected and further grown in suspension for 3 days. At day 5 of differentiation (5d), EBs were plated on gelatine-coated 6-well plates (10 EBs/well) in "Differentiation Medium I" (see Schroeder et al., 2006) and further cultured for 9 days. At day 14 of differentiation (5+9d), EB outgrowths were cultured in "Differentiation Medium II" supplemented with 15% FCS for 24 hours. At day 15 of differentiation (5+10d), cells were refed with "Differentiation Medium II" without FCS until 33 days of differentiation (5+28d).
For immunofluorescence analysis EBs (5d) were plated on gelatinecoated 60 mm dishes (20 EBs/dish). At the stage of 5+9d, EB outgrowths were dissociated by incubation in a solution of 0.1% trypsin (Invitrogen): 0.08% EDTA (Sigma) in PBS (1:1) for 90 seconds at room temperature, collected by centrifugation (300 rpm, 3 min), and replated onto poly-Lornithine/laminin-coated cover slips placed in 60 mm dishes.
Semi-quantitative and real-time PCR analysis
Total RNA was extracted using RNAeasy kits with on-column DNAse digestion (Qiagen, http://www.qiagen.com). Reverse transcription was performed using M-MLV Reverse Transcriptase (Promega Corp., Madison, WI, http://www.promega.com) and Random Primers (MWG-Biotech AG, Ebersberg, Germany, http://www.mwg-biotech.com), according to the manufacturer's recommendations. PCR reactions were performed with a Perkin-Elmer thermal cycler, operating on a regimen of 94°C for 30 sec, 55 to 62°C (according to primers) for 30 sec and 72°C for 60 sec. Primers, annealing temperatures and number of cycles are: Pdx-1: 5'-ACCATGAACAGTGAGGAGCA-3' (forward), 5'-TCCTCTTGTTTTCCTCGGGT-3' (reverse), 58°C, 35 cycles; Nkx2.2: 5'-AACCGTGCCACGCGCTCAAA-3' (forward), 5'-AGGGCCTAAGGCCTCCAGTCT-3' (reverse), 58°C, 34 cycles; Nkx6.1: 5'-TCTTCTGGCCCGGGGTGATG-3' (forward), 5'-AGCCGCGTGCTTCTTCCTCCA-3' (reverse), 62°C, 34 cycles; NeuroD1: 5'-CTTGGCCAAGAACTACATCTGG-3' (forward), 5'-GGAGTAGGGATGCACCGGGAA-3' (reverse), 58°C, 34 cycles; Pax-6: 5'-GCTTCATCCGAGTCTTCTCCGTTAG-3' (forward),
